In 1968 Stella Polaris AS (the north star) was founded in the fishing village of Karvikhamm, high within the Arctic circle. Over the next fifty years, this family-run company grew from a small fishing port into a global leader in premium, sustainable cold-water shrimp production. Though environmental stewardship was paramount to the company, the shrimp shells, discarded during production resulted in undesirable waste. In 2007 Stella Polaris established Marealis AS, a biotech company committed to converting what was once a waste by-product into potent bioactive marine peptides with a significant cardiovascular health benefit. In 2018 PreCardix was introduced to Canada, under the guidance and leadership of a global collective of researchers, business leaders and scientists dedicated to finding a natural, sustainable and effective solution to the growing global hypertension crisis.

Our Corporate Family Tree

Meet the team

Marealis Health Inc.

Andreas Semmingsen
Chief Executive Officer
Norway

Kari de Boer
Chief Marketing Officer
Norway

Øystein Pettersen
Chief Sales Officer
Norway

Carolyn Ansley
Chief Business Development Officer
Canada

Marealis Innovation

Jaran Rauo
Head of R&D
Norway

Heming Hansen
Head of Quality & Production
Norway

Medical Advisory Board

The PreCardix Hypertension Medical Advisory Board provides PreCardix with non-biased information and advice. Participation on the advisory board is not considered a product endorsement.

Louise McCrindle, N.D.
Chair
Canada

Kelly Clinning, BSc (Hon.), N.D.
Advisor
Canada